Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 SAD Study of Ir-CPI in Healthy Male Volunteers
NCT04653766Phase 1Completed
- Sponsor
- Bioxodes
- Start
- Sep 2019
- Primary completion
- Jul 2020
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of BIOX-101 in intracerebral hemorrhage (ICH) (5 arms), sponsored by Bioxodes. Primary endpoint: Activated Partial Thromboplastin Time at Day 10. Started Sep 2019; status: completed.
02
Drugs
BIOX-101
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT04653766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04653766.